Rapid Communication
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Oct 21, 2008; 14(39): 6065-6071
Published online Oct 21, 2008. doi: 10.3748/wjg.14.6065
Drug utilization of clarithromycin for gastrointestinal disease treatment
Quan Zhou, Ling-Ling Zhu, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng
Quan Zhou, Xiao-Feng Yan, Department of Clinical Pharmacy, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province 310009, China
Ling-Ling Zhu, Geriatric Ward, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province 310009, China
Wen-Sheng Pan, Department of gastroenterology, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province 310009, China
Su Zeng, Department of Pharmaceutical Analysis & Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Zhejiang Province 310058, China
Author contributions: Zhou Q and Pan WS contributed equally to this work; Zhou Q and Yan XF put forward the viewpoint and designed this survey; Zhou Q, Zhu LL and Zeng S performed literature review and data analysis/interpretation; and Zhou Q and Pan WS wrote the paper.
Supported by Zhejiang Provincial Bureau of Education, No. 20070227; Zhejiang Medical Association, No. 2007ZYC18 and Association of Zhejiang Hospital Administration, No. 2007AZHA-KEB312
Correspondence to: Quan Zhou, Associate Professor, Department of Clinical Pharmacy, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province 310009, China. zhouquan142602@zju.edu.cn
Telephone: +86-571-87784615 Fax: +86-571-87213864
Received: September 1, 2008
Revised: September 12, 2008
Accepted: September 29, 2008
Published online: October 21, 2008
Core Tip